Enovis to Participate in the Goldman Sachs Global Healthcare Conference
Enovis Corporation (NYSE: ENOV) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 13, 2022. CEO Matt Trerotola and CFO Chris Hix will engage with investors at the event in Rancho Palos Verdes, California. The company, previously known as Colfax Corporation, focuses on innovative medical technology aimed at improving patient outcomes and transforming healthcare workflows.
For more details, visit www.enovis.com.
- None.
- None.
Wilmington, DE, June 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Matt Trerotola, CEO, and Chris Hix, CFO, will be meeting with investors at the conference which is scheduled to take place in Rancho Palos Verdes, California.
ABOUT ENOVIS™
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.
Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-252-9129
investorrelations@enovis.com
Source: Enovis Corporation
FAQ
What is the date of Enovis Corporation's participation in the Goldman Sachs 43rd Annual Global Healthcare Conference?
Who are the key executives representing Enovis at the conference?
Where is the Goldman Sachs Global Healthcare Conference taking place?
What does Enovis Corporation focus on?
What is the stock symbol for Enovis Corporation?
